High-resolution mass spectrometry-based selection of peanut peptide biomarkers considering food processing and market type variation.

High-resolution mass spectrometry Multiple allergen isoforms Peanut origin Peptide biomarker selection Processed food products

Journal

Food chemistry
ISSN: 1873-7072
Titre abrégé: Food Chem
Pays: England
ID NLM: 7702639

Informations de publication

Date de publication:
30 Jan 2020
Historique:
received: 03 06 2019
revised: 14 08 2019
accepted: 24 08 2019
pubmed: 3 9 2019
medline: 4 12 2019
entrez: 3 9 2019
Statut: ppublish

Résumé

To protect allergic patients and guarantee correct food labeling, robust, specific and sensitive detection methods are urgently needed. Mass spectrometry (MS)-based methods could overcome the limitations of current detection techniques. The first step in the development of an MS-based method is the identification of biomarkers, which are, in the case of food allergens, peptides. Here, we implemented a strategy to identify the most salient peptide biomarkers in peanuts. Processed peanut matrices were prepared and analyzed using an untargeted approach via high-resolution MS. More than 300 identified peptides were further filtered using selection criteria to strengthen the analytical performance of a future, routine quantitative method. The resulting 16 peptides are robust to food processing, specific to peanuts, and satisfy sequence-based criteria. The aspect of multiple protein isoforms is also considered in the selection tree, an aspect that is essential for a quantitative method's robustness but seldom, if ever, considered.

Identifiants

pubmed: 31476548
pii: S0308-8146(19)31543-2
doi: 10.1016/j.foodchem.2019.125428
pii:
doi:

Substances chimiques

Allergens 0
Biomarkers 0
Peptides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

125428

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Maxime Gavage (M)

CER Groupe, Rue du Point du Jour 8, 6900 Marloie, Belgium; Laboratory of Biochemistry and Cell Biology (URBC)-Namur Research Institute for Life Sciences (NARILIS), University of Namur, 61, Rue de Bruxelles, 5000 Namur, Belgium.

Kaatje Van Vlierberghe (K)

Flanders Research Institute for Agriculture, Fisheries and Food (ILVO), Brusselsesteenweg 370, 9090 Melle, Belgium.

Christof Van Poucke (C)

Flanders Research Institute for Agriculture, Fisheries and Food (ILVO), Brusselsesteenweg 370, 9090 Melle, Belgium.

Marc De Loose (M)

Flanders Research Institute for Agriculture, Fisheries and Food (ILVO), Brusselsesteenweg 370, 9090 Melle, Belgium.

Kris Gevaert (K)

VIB Center for Medical Biotechnology, Albert Baertsoenkaai 3, B9000 Ghent, Belgium; Department of Biomolecular Medicine, Ghent University, Albert Baertsoenkaai 3, B9000 Ghent, Belgium.

Marc Dieu (M)

Laboratory of Biochemistry and Cell Biology (URBC)-Namur Research Institute for Life Sciences (NARILIS), University of Namur, 61, Rue de Bruxelles, 5000 Namur, Belgium; MaSUN, Mass Spectrometry Facility, University of Namur, 61, Rue de Bruxelles, 5000 Namur, Belgium.

Patsy Renard (P)

Laboratory of Biochemistry and Cell Biology (URBC)-Namur Research Institute for Life Sciences (NARILIS), University of Namur, 61, Rue de Bruxelles, 5000 Namur, Belgium; MaSUN, Mass Spectrometry Facility, University of Namur, 61, Rue de Bruxelles, 5000 Namur, Belgium.

Thierry Arnould (T)

Laboratory of Biochemistry and Cell Biology (URBC)-Namur Research Institute for Life Sciences (NARILIS), University of Namur, 61, Rue de Bruxelles, 5000 Namur, Belgium.

Nathalie Gillard (N)

CER Groupe, Rue du Point du Jour 8, 6900 Marloie, Belgium. Electronic address: n.gillard@cergroupe.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH